p.A667G | TCGA-56-7582 | LUSC | TCGA | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.1111 |
p.A683D | TCGA-BP-5186 | KIRC | TCGA | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.1667 |
p.R677W | TCGA-CD-A4MG | STAD | TCGA | DYR | CBL_MET | 675:677 | Mutation altering degron motif | 0.8634 |
p.R677W | TCGA-EE-A2GN | SKCM | TCGA | DYR | CBL_MET | 675:677 | Mutation altering degron motif | 0.8634 |
p.E684K | TCGA-CV-7568 | HNSC | TCGA | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.1389 |
p.A670T | DO451 | BLCA | ICGC | DYR | CBL_MET | 675:677 | Mutation substituting flanking lysine | 0.3056 |
p.A670T | DO43899 | UCEC | ICGC | DYR | CBL_MET | 675:677 | Mutation substituting flanking lysine | 0.3056 |
p.A670T | DO42592 | UCEC | ICGC | DYR | CBL_MET | 675:677 | Mutation substituting flanking lysine | 0.3056 |
p.A670T | ACH-000728 | Leukemia | CCLE | DYR | CBL_MET | 675:677 | Mutation substituting flanking lysine | 0.3056 |
p.Y676C | DO51592 | CESC | ICGC | DYR | CBL_MET | 675:677 | Mutation altering degron motif | 0.7087 |
p.A681T | DO8447 | COAD | ICGC | DYR | CBL_MET | 675:677 | Mutation blocking phosphorylation signal | 0.6667 |
p.A681T | DO42384 | UCEC | ICGC | DYR | CBL_MET | 675:677 | Mutation blocking phosphorylation signal | 0.6667 |
p.A670V | DO233121 | GACA | ICGC | DYR | CBL_MET | 675:677 | Mutation substituting flanking lysine | 0.3056 |
p.A670V | DO23214 | LINC | ICGC | DYR | CBL_MET | 675:677 | Mutation substituting flanking lysine | 0.3056 |
p.A670V | DO51666 | PAAD | ICGC | DYR | CBL_MET | 675:677 | Mutation substituting flanking lysine | 0.3056 |
p.A670V | DO40918 | UCEC | ICGC | DYR | CBL_MET | 675:677 | Mutation substituting flanking lysine | 0.3056 |
p.A670V | DO52409 | UCEC | ICGC | DYR | CBL_MET | 675:677 | Mutation substituting flanking lysine | 0.3056 |
p.A677T | DO228972 | LICA | ICGC | DYR | CBL_MET | 675:677 | Mutation altering degron motif | 0.7139 |
p.A677T | DO51776 | STAD | ICGC | DYR | CBL_MET | 675:677 | Mutation altering degron motif | 0.7139 |
p.A677T | DO52412 | UCEC | ICGC | DYR | CBL_MET | 675:677 | Mutation altering degron motif | 0.7139 |
p.A677S | DO26414 | LUAD | ICGC | DYR | CBL_MET | 675:677 | Mutation altering degron motif | 0.7588 |
p.G666R | DO23693 | LUAD | ICGC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.0833 |
p.A684G | DO223721 | LUSC | ICGC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.1389 |
p.D686N | DO50690 | ORCA | ICGC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.0833 |
p.S678T | DO47132 | RECA | ICGC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.3056 |
p.S687F | DO47700 | SKCM | ICGC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.0556 |
p.G666V | DO47613 | SKCM | ICGC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.0833 |
p.V683M | DO42600 | UCEC | ICGC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.1667 |
p.A681V | DO41518 | UCEC | ICGC | DYR | CBL_MET | 675:677 | Mutation blocking phosphorylation signal | 0.6667 |
p.R673Q | SIDM01007 | T-Lymphoblastic Leukemia | GDSC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.2778 |
p.A667T | SIDM00282 | Colorectal Carcinoma | GDSC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.1111 |
p.G666E | ACH-000220 | Lymphoma | CCLE | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.0833 |
p.P673L | ACH-000308 | Ovarian Cancer | CCLE | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.2778 |
p.P673L | EFO-21 | ovary | COSMIC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.2778 |
p.P669S | ACH-000325 | Gastric Cancer | CCLE | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.1667 |
p.S678N | ACH-000987 | Skin Cancer | CCLE | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.3056 |
p.S678N | Mewo | skin | COSMIC | DYR | CBL_MET | 675:677 | Mutation rewiring degron network | 0.3056 |
p.Y668N | ACH-001802 | Liposarcoma | CCLE | DYR | CBL_MET | 675:677 | Mutation substituting flanking lysine | 0.25 |